Literature DB >> 18427358

Plasma lipid-dependent and -independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden.

Sara E Walker1, Thomas C Register, Susan E Appt, Michael R Adams, Thomas B Clarkson, Haiying Chen, Scott Isom, Adrian A Franke, Jay R Kaplan.   

Abstract

OBJECTIVE: : Atherosclerosis developed during premenopausal years predicts postmenopausal atherosclerosis burden. The objective of this study was to determine the effects of dietary soy protein isolate (SPI) and social status on atherogenesis and arterial gene expression in a premenopausal monkey model.
DESIGN: : Socially housed premenopausal cynomolgus macaques (n = 84) were fed an atherogenic diet deriving protein from casein/lactalbumin or SPI (containing 1.88 mg isoflavones/g). After 36 months of diet consumption, iliac artery biopsies were assessed for atherosclerosis and expression of mRNA transcripts related to inflammation, macrophage and T-cell content, and estrogen receptors (ERs).
RESULTS: : SPI reduced plaque size (P < 0.05), total plasma cholesterol, non-high-density lipoprotein cholesterol (HDLc), and the total plasma cholesterol/HDLc ratio (all P < 0.003), while increasing triglycerides (P < 0.006) and HDLc (P < 0.0001). Arterial mRNA for CD68 (P < 0.001), CD3 (P < 0.02), and CD4 (P < 0.001) and inflammatory markers monocyte chemotactic protein-1, intercellular adhesion molecule-1, and interleukin-6 (all P < 0.0001) were also lower in the group receiving SPI. For most outcomes, this effect remained even after adjustments for plaque size and plasma lipid concentrations. Arterial ER-alpha was inversely associated with atherosclerosis (P < 0.02) and increased with SPI (P < 0.001). Subordinate monkeys had lower ER-beta (P < 0.02) and higher interleukin-6 (P < 0.05) transcripts but did not differ from dominant monkeys in extent of atherosclerosis (P > 0.9).
CONCLUSIONS: : Premenopausal consumption of SPI had plasma lipid-independent beneficial effects on the pathobiological processes involved in atherosclerotic plaque development, thus potentially establishing the basis for reduced postmenopausal complications. Dominant social status provided similar, albeit less extensive, benefits in risk markers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427358      PMCID: PMC3417141          DOI: 10.1097/gme.0b013e3181612cef

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  38 in total

1.  AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA.

Authors:  J W Erdman
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice.

Authors:  J B Hodgin; J H Krege; R L Reddick; K S Korach; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects.

Authors:  Alice H Lichtenstein; Susan M Jalbert; Herman Adlercreutz; Barry R Goldin; Helen Rasmussen; Ernst J Schaefer; Lynne M Ausman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

5.  The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha.

Authors:  Michael R Adams; Deborah L Golden; Thomas C Register; Mary S Anthony; Jeffrey B Hodgin; Nobuyo Maeda; J Koudy Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

6.  Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys.

Authors:  J R Kaplan; S B Manuck; M S Anthony; T B Clarkson
Journal:  Obstet Gynecol       Date:  2002-03       Impact factor: 7.661

7.  Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo.

Authors:  M J Evans; A Eckert; K Lai; S J Adelman; D C Harnish
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

Review 8.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood.

Authors:  Adrian A Franke; Laurie J Custer; Lynne R Wilkens; Loïc Le Le Marchand; Abraham M Y Nomura; Marc T Goodman; Laurence N Kolonel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-09-25       Impact factor: 3.205

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  21 in total

1.  The effect of diet and cardiovascular risk on ovarian aging in cynomolgus monkeys (Macaca fascicularis).

Authors:  Susan E Appt; Haiying Chen; Amanda K Goode; Patricia B Hoyer; Thomas B Clarkson; Michael R Adams; Mark E Wilson; Adrian A Franke; Jay R Kaplan
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 2.  The development of small primate models for aging research.

Authors:  Kathleen E Fischer; Steven N Austad
Journal:  ILAR J       Date:  2011

3.  Molecular and cellular profiling of acute responses to total body radiation exposure in ovariectomized female cynomolgus macaques.

Authors:  Ryne J DeBo; Thomas C Register; David L Caudell; Gregory D Sempowski; Gregory Dugan; Shauna Gray; Kouros Owzar; Chen Jiang; J Daniel Bourland; Nelson J Chao; J Mark Cline
Journal:  Int J Radiat Biol       Date:  2015-04-22       Impact factor: 2.694

4.  Effect of soy isoflavones on thyroid hormones in intact and ovariectomized cynomolgus monkeys (Macaca fascicularis).

Authors:  Marnie G Silverstein; Jay R Kaplan; Susan E Appt; Thomas C Register; Carol A Shively
Journal:  Menopause       Date:  2014-10       Impact factor: 2.953

5.  The effect of dietary soy isoflavones before and after ovariectomy on hippocampal protein markers of mitochondrial bioenergetics and antioxidant activity in female monkeys.

Authors:  Jamaica R Rettberg; Ryan T Hamilton; Zisu Mao; Jimmy To; Liqin Zhao; Susan E Appt; Thomas C Register; Jay R Kaplan; Roberta Diaz Brinton
Journal:  Brain Res       Date:  2011-01-14       Impact factor: 3.252

6.  Effect of ovarian aging on androgen biosynthesis in a cynomolgus macaque model.

Authors:  K F Ethun; C E Wood; C R Parker; J R Kaplan; H Chen; S E Appt
Journal:  Climacteric       Date:  2011-08-24       Impact factor: 3.005

7.  Effects of equol on gene expression in female cynomolgus monkey iliac arteries.

Authors:  K Eyster; S Appt; A Chalpe; T Register; T Clarkson
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-11-01       Impact factor: 4.222

8.  Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.

Authors:  Areepan Sophonsritsuk; Susan E Appt; Thomas B Clarkson; Carol A Shively; Mark A Espeland; Thomas C Register
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

9.  Serum antimüllerian hormone predicts ovarian reserve in a monkey model.

Authors:  Susan E Appt; Thomas B Clarkson; Haiying Chen; Michael R Adams; Patricia J Christian; Patricia B Hoyer; Mark E Wilson; Jay R Kaplan
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

Review 10.  Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis).

Authors:  Thomas C Register
Journal:  Am J Primatol       Date:  2009-09       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.